Aromatic Arsenic Drug Triphenylarsine Oxide
Triphenylarsine oxide is an aromatic organo-arsenic compound used as an intermediate in pharmaceutical synthesis for anti-cancer drugs. It falls under HTS 2931.90.22.00 as an aromatic organo-inorganic drug containing arsenic directly linked to carbon, meeting Chapter 29 requirements for chemically defined compounds.
Import Duty Rates by Country of Origin
Alternative Classifications
This product could be classified differently depending on its characteristics or intended use.
If not specifically designated as a drug
Organo-arsenic compounds without established drug use fall under the general organo-arsenic subheading.
If containing nucleic acids or derivatives
Organic compounds with nucleic acid functions are classified in Chapter 29 heading 2942 regardless of organo-inorganic nature.
If imported as formulated pharmaceutical dosage form
Finished drug products in dosage form (tablets, capsules) move to Chapter 30, not remaining in bulk chemical Chapter 29.
Not sure which classification is right?
Our AI classifier can analyze your specific product and recommend the correct HTS code with confidence.
Import Tips & Compliance
• Provide detailed chemical analysis and CAS number to confirm arsenic-carbon linkage for Chapter 29 classification
• Include FDA import alerts documentation for arsenic-containing pharmaceuticals to avoid detention
• Verify 'drug' status with therapeutic use evidence to distinguish from non-drug organo-inorganics
Related Products under HTS 2931.90.22.00
4-Dimethylaminophenylarsine Drug Intermediate
This aromatic organo-arsenic compound serves as a key intermediate in synthesizing anti-parasitic drugs. Classified under HTS 2931.90.22.00 due to its aromatic structure with arsenic directly bonded to carbon and designated pharmaceutical application.
Phenylphosphine Gold Drug Auranofin Intermediate
Auranofin intermediate featuring aromatic phosphine coordinated with gold, used in rheumatoid arthritis treatment. Falls under HTS 2931.90.22.00 as an aromatic organo-inorganic drug with phosphorus and metal directly linked to aromatic carbon.
Aromatic Silane Platinum Anti-Cancer Drug
Platinum-based chemotherapy agent with aromatic silane ligands, used in cancer treatment protocols. HTS 2931.90.22.00 classification applies to this aromatic organo-inorganic compound containing silicon and platinum linked to carbon.
Organotin Aromatic Drug Candidate
Aromatic organotin compound under development for anti-microbial pharmaceutical applications. Classified in HTS 2931.90.22.00 as an aromatic organo-inorganic drug with tin directly bonded to aromatic carbon.
Ferrocene Aromatic Drug Derivative
Ferrocene-based aromatic metallocene used in anti-cancer drug development with iron-carbon sandwich structure. HTS 2931.90.22.00 covers this aromatic organo-inorganic pharmaceutical as metal is linked through carbon atoms.
Aryl Boronic Acid Platinum Drug Complex
Platinum anti-tumor agent featuring aromatic boronic acid ligands for targeted cancer therapy. Falls under HTS 2931.90.22.00 as aromatic organo-inorganic containing boron and platinum linked to carbon.